(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMUNOVIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

IMUNOVIR

ST13

US500000079068731

Class

5

Filing

79068731

Registration

3747053

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

11/21/2021

Trademark type

Combined

Nice classes

5

Filing date

04/17/2009

Registration date

02/09/2010

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/10/2020

Last transaction

03/10/2020

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

Swords, County Dublin, IE

Examiner

RIRIE, VERNA

Law office

L40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Newport Pharmaceuticals Limited
Newport Pharmaceuticals Limited

Representatives

G. Gregory Schivley / Geoffrey D. Aurini Harness, Dickey & Pierce, P.L.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productsantivirals and immunostimulants

Publications

History of USPTO decisions and trademark events.

38 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/21/2021

RNWL

INTERNATIONAL REGISTRATION RENEWED

04/01/2021

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

03/10/2020

71AG

REGISTERED-SEC.71 ACCEPTED

03/10/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/05/2019

ES71

TEAS SECTION 71 RECEIVED

11/05/2019

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

02/09/2019

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

03/30/2016

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

03/30/2016

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

03/03/2016

PR75

POST REGISTRATION ACTION MAILED - SEC. 71 & 15

01/21/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/21/2016

ES75

TEAS SECTION 71 & 15 RECEIVED

12/16/2015

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

08/31/2012

RNWL

INTERNATIONAL REGISTRATION RENEWED

03/24/2011

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

09/03/2010

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/07/2010

FIMP

FINAL DISPOSITION PROCESSED

06/07/2010

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/10/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

02/09/2010

PUBO

PUBLISHED FOR OPPOSITION

11/24/2009

NPUB

NOTICE OF PUBLICATION

11/04/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/22/2009

ALIE

ASSIGNED TO LIE

10/22/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/02/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/02/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/01/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/01/2009

RFNT

REFUSAL PROCESSED BY IB

08/21/2009

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/13/2009

RFRR

REFUSAL PROCESSED BY MPU

07/13/2009

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/11/2009

CNRT

NON-FINAL ACTION WRITTEN

07/10/2009

DOCK

ASSIGNED TO EXAMINER

07/07/2009

MAFR

APPLICATION FILING RECEIPT MAILED

06/19/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/15/2009

LIMS

LIMITATION OF GOODS/SERVICES FROM IB ENTERED

06/12/2009

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

06/11/2009

Continuous trademark protection

Get notified about every new filing that threatens IMUNOVIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.